Bridgeway Capital Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-19,020
| Closed | -$956K | – | 1297 |
|
|
2024
Q2 | $956K | Buy |
19,020
+9,728
| +105% | +$489K | 0.02% | 700 |
|
|
2024
Q1 | $1.04M | Hold |
9,292
| – | – | 0.02% | 737 |
|
|
2023
Q4 | $539K | Sell |
9,292
-13,976
| -60% | -$811K | 0.01% | 922 |
|
|
2023
Q3 | $739K | Buy |
+23,268
| New | +$739K | 0.02% | 789 |
|
|
2020
Q1 | – | Sell |
-6,376
| Closed | -$913K | – | 1332 |
|
|
2019
Q4 | $913K | Buy |
6,376
+1,864
| +41% | +$267K | 0.01% | 762 |
|
|
2019
Q3 | $178K | Buy |
4,512
+2,520
| +127% | +$99.4K | ﹤0.01% | 1199 |
|
|
2019
Q2 | $202K | Hold |
1,992
| – | – | ﹤0.01% | 1177 |
|
|
2019
Q1 | $262K | Buy |
+1,992
| New | +$262K | ﹤0.01% | 1178 |
|